291 related articles for article (PubMed ID: 10468583)
1. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.
Georgescu MM; Kirsch KH; Akagi T; Shishido T; Hanafusa H
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10182-7. PubMed ID: 10468583
[TBL] [Abstract][Full Text] [Related]
2. Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.
Georgescu MM; Kirsch KH; Kaloudis P; Yang H; Pavletich NP; Hanafusa H
Cancer Res; 2000 Dec; 60(24):7033-8. PubMed ID: 11156408
[TBL] [Abstract][Full Text] [Related]
3. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
[TBL] [Abstract][Full Text] [Related]
4. PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase.
Wu Y; Dowbenko D; Pisabarro MT; Dillard-Telm L; Koeppen H; Lasky LA
J Biol Chem; 2001 Jun; 276(24):21745-53. PubMed ID: 11279206
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of H-Ras transformation by the PTEN/MMAC1/TEP1 tumor suppressor gene.
Tolkacheva T; Chan AM
Oncogene; 2000 Feb; 19(5):680-9. PubMed ID: 10698513
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.
Torres J; Pulido R
J Biol Chem; 2001 Jan; 276(2):993-8. PubMed ID: 11035045
[TBL] [Abstract][Full Text] [Related]
7. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
[TBL] [Abstract][Full Text] [Related]
8. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
[TBL] [Abstract][Full Text] [Related]
9. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
Li DM; Sun H
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.
Lee JO; Yang H; Georgescu MM; Di Cristofano A; Maehama T; Shi Y; Dixon JE; Pandolfi P; Pavletich NP
Cell; 1999 Oct; 99(3):323-34. PubMed ID: 10555148
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the PTEN tail regulates protein stability and function.
Vazquez F; Ramaswamy S; Nakamura N; Sellers WR
Mol Cell Biol; 2000 Jul; 20(14):5010-8. PubMed ID: 10866658
[TBL] [Abstract][Full Text] [Related]
13. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases.
Valiente M; Andrés-Pons A; Gomar B; Torres J; Gil A; Tapparel C; Antonarakis SE; Pulido R
J Biol Chem; 2005 Aug; 280(32):28936-43. PubMed ID: 15951562
[TBL] [Abstract][Full Text] [Related]
14. Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.
Han SY; Kato H; Kato S; Suzuki T; Shibata H; Ishii S; Shiiba K; Matsuno S; Kanamaru R; Ishioka C
Cancer Res; 2000 Jun; 60(12):3147-51. PubMed ID: 10866302
[TBL] [Abstract][Full Text] [Related]
15. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
Wu X; Hepner K; Castelino-Prabhu S; Do D; Kaye MB; Yuan XJ; Wood J; Ross C; Sawyers CL; Whang YE
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4233-8. PubMed ID: 10760291
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase.
Wu Y; Dowbenko D; Spencer S; Laura R; Lee J; Gu Q; Lasky LA
J Biol Chem; 2000 Jul; 275(28):21477-85. PubMed ID: 10748157
[TBL] [Abstract][Full Text] [Related]
17. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein.
Okahara F; Ikawa H; Kanaho Y; Maehama T
J Biol Chem; 2004 Oct; 279(44):45300-3. PubMed ID: 15355975
[TBL] [Abstract][Full Text] [Related]
18. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
19. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.
Leslie NR; Gray A; Pass I; Orchiston EA; Downes CP
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):827-33. PubMed ID: 10698713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
